Emergence and antigenic characterisation of influenza A(H3N2) viruses with hemagglutinin substitutions N158K and K189R during the 2024/25 influenza season.
Saved in:
| Title: | Emergence and antigenic characterisation of influenza A(H3N2) viruses with hemagglutinin substitutions N158K and K189R during the 2024/25 influenza season. |
|---|---|
| Authors: | Koel B; Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands., Byrne AM; WHO Collaborating Centre for Reference and Research on Influenza, Worldwide Influenza Centre, the Francis Crick Institute, London, United Kingdom., Turner S; Center for Pathogen Evolution, University of Cambridge, Cambridge, United Kingdom., James S; Center for Pathogen Evolution, University of Cambridge, Cambridge, United Kingdom., Harvey R; WHO Collaborating Centre for Reference and Research on Influenza, Worldwide Influenza Centre, the Francis Crick Institute, London, United Kingdom., Galiano M; WHO Collaborating Centre for Reference and Research on Influenza, Worldwide Influenza Centre, the Francis Crick Institute, London, United Kingdom., Carr C; WHO Collaborating Centre for Reference and Research on Influenza, Worldwide Influenza Centre, the Francis Crick Institute, London, United Kingdom., Lexmond P; Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands., Pronk M; Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands., Liang R; Department of Chemical Biology & Drug Discovery, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands., Boons GJ; Department of Chemical Biology & Drug Discovery, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands.; Complex Carbohydrate Research Center, Department of Chemistry, Athens, USA.; Center for Influenza Disease and Emergence Response, University of Georgia, Athens, USA.; Department of Chemistry, University of Georgia, Athens, USA., de Vries RP; Department of Chemical Biology & Drug Discovery, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands., Eggink D; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands., Lewis N; WHO Collaborating Centre for Reference and Research on Influenza, Worldwide Influenza Centre, the Francis Crick Institute, London, United Kingdom., Smith D; Center for Pathogen Evolution, University of Cambridge, Cambridge, United Kingdom., Meijer A; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands., Fouchier R; Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands. |
| Source: | BioRxiv : the preprint server for biology [bioRxiv] 2026 Feb 10. Date of Electronic Publication: 2026 Feb 10. |
| Publication Type: | Journal Article; Preprint |
| Journal Info: | Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41727041 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Emergence and antigenic characterisation of influenza A(H3N2) viruses with hemagglutinin substitutions N158K and K189R during the 2024/25 influenza season. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Koel+B%22">Koel B</searchLink>; Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Byrne+AM%22">Byrne AM</searchLink>; WHO Collaborating Centre for Reference and Research on Influenza, Worldwide Influenza Centre, the Francis Crick Institute, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Turner+S%22">Turner S</searchLink>; Center for Pathogen Evolution, University of Cambridge, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22James+S%22">James S</searchLink>; Center for Pathogen Evolution, University of Cambridge, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Harvey+R%22">Harvey R</searchLink>; WHO Collaborating Centre for Reference and Research on Influenza, Worldwide Influenza Centre, the Francis Crick Institute, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Galiano+M%22">Galiano M</searchLink>; WHO Collaborating Centre for Reference and Research on Influenza, Worldwide Influenza Centre, the Francis Crick Institute, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Carr+C%22">Carr C</searchLink>; WHO Collaborating Centre for Reference and Research on Influenza, Worldwide Influenza Centre, the Francis Crick Institute, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Lexmond+P%22">Lexmond P</searchLink>; Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Pronk+M%22">Pronk M</searchLink>; Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Liang+R%22">Liang R</searchLink>; Department of Chemical Biology & Drug Discovery, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Boons+GJ%22">Boons GJ</searchLink>; Department of Chemical Biology & Drug Discovery, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands.; Complex Carbohydrate Research Center, Department of Chemistry, Athens, USA.; Center for Influenza Disease and Emergence Response, University of Georgia, Athens, USA.; Department of Chemistry, University of Georgia, Athens, USA.<br /><searchLink fieldCode="AU" term="%22de+Vries+RP%22">de Vries RP</searchLink>; Department of Chemical Biology & Drug Discovery, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Eggink+D%22">Eggink D</searchLink>; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Lewis+N%22">Lewis N</searchLink>; WHO Collaborating Centre for Reference and Research on Influenza, Worldwide Influenza Centre, the Francis Crick Institute, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Smith+D%22">Smith D</searchLink>; Center for Pathogen Evolution, University of Cambridge, Cambridge, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Meijer+A%22">Meijer A</searchLink>; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Fouchier+R%22">Fouchier R</searchLink>; Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101680187%22">BioRxiv : the preprint server for biology</searchLink> [bioRxiv] 2026 Feb 10. <i>Date of Electronic Publication: </i>2026 Feb 10. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Preprint – Name: TitleSource Label: Journal Info Group: Src Data: <i>Country of Publication: </i>United States <i>NLM ID: </i>101680187 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2692-8205 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226928205%22">26928205 </searchLink><i>NLM ISO Abbreviation: </i>bioRxiv <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41727041 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.64898/2026.02.10.704996 Languages: – Code: eng Text: English Titles: – TitleFull: Emergence and antigenic characterisation of influenza A(H3N2) viruses with hemagglutinin substitutions N158K and K189R during the 2024/25 influenza season. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Koel B – PersonEntity: Name: NameFull: Byrne AM – PersonEntity: Name: NameFull: Turner S – PersonEntity: Name: NameFull: James S – PersonEntity: Name: NameFull: Harvey R – PersonEntity: Name: NameFull: Galiano M – PersonEntity: Name: NameFull: Carr C – PersonEntity: Name: NameFull: Lexmond P – PersonEntity: Name: NameFull: Pronk M – PersonEntity: Name: NameFull: Liang R – PersonEntity: Name: NameFull: Boons GJ – PersonEntity: Name: NameFull: de Vries RP – PersonEntity: Name: NameFull: Eggink D – PersonEntity: Name: NameFull: Lewis N – PersonEntity: Name: NameFull: Smith D – PersonEntity: Name: NameFull: Meijer A – PersonEntity: Name: NameFull: Fouchier R IsPartOfRelationships: – BibEntity: Dates: – D: 10 M: 02 Text: 2026 Feb 10 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2692-8205 Titles: – TitleFull: BioRxiv : the preprint server for biology Type: main |
| ResultId | 1 |
